{ "@graph": [    { "@id": "http://linked.opendata.cz/resource/ATC/C",      "@type" : [ "http://linked.opendata.cz/ontology/drug-encyclopedia/ATCConcept" ] ,      "http://purl.org/dc/terms/title" : [ { "@value" : "Kardiovaskul\u00E1rn\u00ED syst\u00E9m" , "@language" : "cs" } ,        { "@value" : "CARDIOVASCULAR SYSTEM" , "@language" : "en" } ] ,      "http://www.w3.org/2004/02/skos/core#notation" : [ { "@value" : "C" } ] } ,    { "@id": "http://linked.opendata.cz/resource/ATC/C09",      "@type" : [ "http://linked.opendata.cz/ontology/drug-encyclopedia/ATCConcept" ] ,      "http://purl.org/dc/terms/title" : [ { "@value" : "AGENTS ACTING ON THE RENIN-ANGIOTENSIN SYSTEM" , "@language" : "en" } ,        { "@value" : "L\u00E9\u010Diva ovliv\u0148uj\u00EDc\u00ED renin-angiotenzinov\u00FD syst\u00E9m" , "@language" : "cs" } ] ,      "http://www.w3.org/2004/02/skos/core#notation" : [ { "@value" : "C09" } ] } ,    { "@id": "http://linked.opendata.cz/resource/ATC/C09B",      "@type" : [ "http://linked.opendata.cz/ontology/drug-encyclopedia/ATCConcept" ] ,      "http://purl.org/dc/terms/title" : [ { "@value" : "ACE INHIBITORS, COMBINATIONS" , "@language" : "en" } ,        { "@value" : "ACE inhibitory, kombinace" , "@language" : "cs" } ] ,      "http://www.w3.org/2004/02/skos/core#notation" : [ { "@value" : "C09B" } ] } ,    { "@id": "http://linked.opendata.cz/resource/ATC/C09BB",      "@type" : [ "http://linked.opendata.cz/ontology/drug-encyclopedia/ATCConcept" ] ,      "http://purl.org/dc/terms/title" : [ { "@value" : "ACE inhibitors and calcium channel blockers" , "@language" : "en" } ,        { "@value" : "ACE inhibitory a blok\u00E1tory kalciov\u00FDch kan\u00E1l\u016F" , "@language" : "cs" } ] ,      "http://www.w3.org/2004/02/skos/core#notation" : [ { "@value" : "C09BB" } ] } ,    { "@id": "http://linked.opendata.cz/resource/ATC/C09BB07",      "@type" : [ "http://linked.opendata.cz/ontology/drug-encyclopedia/ATCConcept" ] ,      "http://www.w3.org/2004/02/skos/core#broaderTransitive" : [ "http://linked.opendata.cz/resource/ATC/C09BB" ,        "http://linked.opendata.cz/resource/ATC/C09" ,        "http://linked.opendata.cz/resource/ATC/C" ,        "http://linked.opendata.cz/resource/ATC/C09B" ] ,      "http://purl.org/dc/terms/title" : [ { "@value" : "Ramipril a amlodipin" , "@language" : "cs" } ,        { "@value" : "Ramipril and amlodipine " , "@language" : "en" } ] ,      "http://www.w3.org/2004/02/skos/core#notation" : [ { "@value" : "C09BB07" } ] } ,    { "@id": "http://linked.opendata.cz/resource/ndfrt/disease/N0000000999",      "@type" : [ "http://linked.opendata.cz/ontology/drug-encyclopedia/DiseaseOrFinding" ] ,      "http://linked.opendata.cz/ontology/drug-encyclopedia/title" : [ { "@value" : "Drug hypersensitivity" , "@language" : "en" } ,        { "@value" : "L\u00E9kov\u00E1 alergie" , "@language" : "cs" } ] } ,    { "@id": "http://linked.opendata.cz/resource/ndfrt/disease/N0000010195",      "@type" : [ "http://linked.opendata.cz/ontology/drug-encyclopedia/DiseaseOrFinding" ] ,      "http://linked.opendata.cz/ontology/drug-encyclopedia/title" : [ { "@value" : "T\u011Bhotenstv\u00ED" , "@language" : "cs" } ,        { "@value" : "Pregnancy" , "@language" : "en" } ] } ,    { "@id": "http://linked.opendata.cz/resource/ndfrt/disease/N0000001649",      "@type" : [ "http://linked.opendata.cz/ontology/drug-encyclopedia/DiseaseOrFinding" ] ,      "http://linked.opendata.cz/ontology/drug-encyclopedia/title" : [ { "@value" : "Hypotension" , "@language" : "en" } ,        { "@value" : "Hypotenze" , "@language" : "cs" } ] } ,    { "@id": "http://linked.opendata.cz/resource/ndfrt/disease/N0000001573",      "@type" : [ "http://linked.opendata.cz/ontology/drug-encyclopedia/DiseaseOrFinding" ] ,      "http://linked.opendata.cz/ontology/drug-encyclopedia/title" : [ { "@value" : "Hyperaldosteronism" , "@language" : "en" } ,        { "@value" : "Hyperaldosteronismus" , "@language" : "cs" } ] } ,    { "@id": "http://linked.opendata.cz/resource/ndfrt/disease/N0000000415",      "@type" : [ "http://linked.opendata.cz/ontology/drug-encyclopedia/DiseaseOrFinding" ] ,      "http://linked.opendata.cz/ontology/drug-encyclopedia/title" : [ { "@value" : "Angioedema" , "@language" : "en" } ,        { "@value" : "Angioed\u00E9m" , "@language" : "cs" } ] } ,    { "@id": "http://linked.opendata.cz/resource/drug-encyclopedia/ingredient/M0026284",      "@type" : [ "http://linked.opendata.cz/ontology/drug-encyclopedia/Ingredient" ] ,      "http://linked.opendata.cz/ontology/drug-encyclopedia/title" : [ { "@value" : "Amlodipin" , "@language" : "cs" } ,        { "@value" : "Amlodipine" , "@language" : "en" } ] ,      "http://linked.opendata.cz/ontology/drug-encyclopedia/hasPharmacologicalAction" : [ "http://linked.opendata.cz/resource/drug-encyclopedia/pharmacological-action/M0001456" ,        "http://linked.opendata.cz/resource/drug-encyclopedia/pharmacological-action/M0003165" ,        "http://linked.opendata.cz/resource/drug-encyclopedia/pharmacological-action/M0022559" ] ,      "http://linked.opendata.cz/ontology/drug-encyclopedia/description" : [ { "@value" : "A long-acting dihydropyridine calcium channel blocker. It is effective in the treatment of ANGINA PECTORIS and HYPERTENSION.     " , "@language" : "en" } ] ,      "http://linked.opendata.cz/ontology/drug-encyclopedia/hasPregnancyCategory" : [ "http://linked.opendata.cz/resource/fda-spl/pregnancy-category/C" ] ,      "http://linked.opendata.cz/ontology/drug-encyclopedia/contraindicatedWith" : [ "http://linked.opendata.cz/resource/ndfrt/disease/N0000001649" ,        "http://linked.opendata.cz/resource/ndfrt/disease/N0000000999" ] } ,    { "@id": "http://linked.opendata.cz/resource/drug-encyclopedia/ingredient/M0026184",      "@type" : [ "http://linked.opendata.cz/ontology/drug-encyclopedia/Ingredient" ] ,      "http://linked.opendata.cz/ontology/drug-encyclopedia/title" : [ { "@value" : "Ramipril" , "@language" : "en" } ,        { "@value" : "Ramipril" , "@language" : "cs" } ] ,      "http://linked.opendata.cz/ontology/drug-encyclopedia/hasPharmacologicalAction" : [ "http://linked.opendata.cz/resource/drug-encyclopedia/pharmacological-action/M0001207" ,        "http://linked.opendata.cz/resource/drug-encyclopedia/pharmacological-action/M0001456" ] ,      "http://linked.opendata.cz/ontology/drug-encyclopedia/description" : [ { "@value" : "A long-acting angiotensin-converting enzyme inhibitor. It is a prodrug that is transformed in the liver to its active metabolite ramiprilat.     " , "@language" : "en" } ] ,      "http://linked.opendata.cz/ontology/drug-encyclopedia/contraindicatedWith" : [ "http://linked.opendata.cz/resource/ndfrt/disease/N0000000999" ,        "http://linked.opendata.cz/resource/ndfrt/disease/N0000010195" ,        "http://linked.opendata.cz/resource/ndfrt/disease/N0000000415" ,        "http://linked.opendata.cz/resource/ndfrt/disease/N0000001573" ,        "http://linked.opendata.cz/resource/ndfrt/disease/N0000001649" ] } ,    { "@id": "http://linked.opendata.cz/resource/sukl/medicinal-product/EGIRAMLON-2-5-MG-2-5-MG",      "@type" : [ "http://linked.opendata.cz/ontology/drug-encyclopedia/MedicinalProduct" ] ,      "http://linked.opendata.cz/ontology/drug-encyclopedia/hasActiveIngredient" : [ "http://linked.opendata.cz/resource/drug-encyclopedia/ingredient/M0026284" ,        "http://linked.opendata.cz/resource/drug-encyclopedia/ingredient/M0026184" ] ,      "http://linked.opendata.cz/ontology/drug-encyclopedia/title" : [ { "@value" : "EGIRAMLON 2,5 MG/2,5 MG" , "@language" : "cs" } ] ,      "http://linked.opendata.cz/ontology/drug-encyclopedia/hasATCConcept" : [ "http://linked.opendata.cz/resource/ATC/C09BB07" ] ,      "http://linked.opendata.cz/ontology/drug-encyclopedia/hasPregnancyCategory" : [ "http://linked.opendata.cz/resource/fda-spl/pregnancy-category/C" ] ,      "http://linked.opendata.cz/ontology/drug-encyclopedia/hasMedicinalProductPackaging" : [ "http://linked.opendata.cz/resource/sukl/medicinal-product-packaging/0177276" ,        "http://linked.opendata.cz/resource/sukl/medicinal-product-packaging/0177272" ,        "http://linked.opendata.cz/resource/sukl/medicinal-product-packaging/0177273" ,        "http://linked.opendata.cz/resource/sukl/medicinal-product-packaging/0177275" ,        "http://linked.opendata.cz/resource/sukl/medicinal-product-packaging/0177274" ] } ,    { "@id": "http://linked.opendata.cz/resource/drug-encyclopedia/pharmacological-action/M0001207",      "@type" : [ "http://linked.opendata.cz/ontology/drug-encyclopedia/PharmacologicalAction" ] ,      "http://linked.opendata.cz/ontology/drug-encyclopedia/title" : [ { "@value" : "Inhibitory angiotenzin konvertuj\u00EDc\u00EDho enzymu" , "@language" : "cs" } ,        { "@value" : "Angiotensin-converting enzyme inhibitors" , "@language" : "en" } ] ,      "http://linked.opendata.cz/ontology/drug-encyclopedia/description" : [ { "@value" : "A class of drugs whose main indications are the treatment of hypertension and heart failure. They exert their hemodynamic effect mainly by inhibiting the renin-angiotensin system. They also modulate sympathetic nervous system activity and increase prostaglandin synthesis. They cause mainly vasodilation and mild natriuresis without affecting heart rate and contractility.     " , "@language" : "en" } ] } ,    { "@id": "http://linked.opendata.cz/resource/drug-encyclopedia/pharmacological-action/M0001456",      "@type" : [ "http://linked.opendata.cz/ontology/drug-encyclopedia/PharmacologicalAction" ] ,      "http://linked.opendata.cz/ontology/drug-encyclopedia/title" : [ { "@value" : "Antihypertensive agents" , "@language" : "en" } ,        { "@value" : "Antihypertenz\u00EDva" , "@language" : "cs" } ] ,      "http://linked.opendata.cz/ontology/drug-encyclopedia/description" : [ { "@value" : "Drugs used in the treatment of acute or chronic vascular HYPERTENSION regardless of pharmacological mechanism. Among the antihypertensive agents are DIURETICS; (especially DIURETICS, THIAZIDE); ADRENERGIC BETA-ANTAGONISTS; ADRENERGIC ALPHA-ANTAGONISTS; ANGIOTENSIN-CONVERTING ENZYME INHIBITORS; CALCIUM CHANNEL BLOCKERS; GANGLIONIC BLOCKERS; and VASODILATOR AGENTS.     " , "@language" : "en" } ] } ,    { "@id": "http://linked.opendata.cz/resource/drug-encyclopedia/pharmacological-action/M0003165",      "@type" : [ "http://linked.opendata.cz/ontology/drug-encyclopedia/PharmacologicalAction" ] ,      "http://linked.opendata.cz/ontology/drug-encyclopedia/title" : [ { "@value" : "Calcium channel blockers" , "@language" : "en" } ,        { "@value" : "Blok\u00E1tory kalciov\u00FDch kan\u00E1l\u016F" , "@language" : "cs" } ] ,      "http://linked.opendata.cz/ontology/drug-encyclopedia/description" : [ { "@value" : "A class of drugs that act by selective inhibition of calcium influx through cell membranes or on the release and binding of calcium in intracellular pools. Since they are inducers of vascular and other smooth muscle relaxation, they are used in the drug therapy of hypertension and cerebrovascular spasms, as myocardial protective agents, and in the relaxation of uterine spasms.     " , "@language" : "en" } ] } ,    { "@id": "http://linked.opendata.cz/resource/drug-encyclopedia/pharmacological-action/M0022559",      "@type" : [ "http://linked.opendata.cz/ontology/drug-encyclopedia/PharmacologicalAction" ] ,      "http://linked.opendata.cz/ontology/drug-encyclopedia/title" : [ { "@value" : "Vasodilator agents" , "@language" : "en" } ,        { "@value" : "Vasodilatancia" , "@language" : "cs" } ] ,      "http://linked.opendata.cz/ontology/drug-encyclopedia/description" : [ { "@value" : "Drugs used to cause dilation of the blood vessels.     " , "@language" : "en" } ] } ,    { "@id": "http://linked.opendata.cz/resource/sukl/medicinal-product-packaging/0177274",      "@type" : [ "http://linked.opendata.cz/ontology/drug-encyclopedia/MedicinalProductPackaging" ] ,      "http://linked.opendata.cz/ontology/drug-encyclopedia/title" : [ { "@value" : "EGIRAMLON 2,5 MG/2,5 MG" , "@language" : "cs" } ] ,      "http://linked.opendata.cz/ontology/drug-encyclopedia/hasATCConcept" : [ "http://linked.opendata.cz/resource/ATC/C09BB07" ] ,      "http://linked.opendata.cz/ontology/drug-encyclopedia/hasIndicationGroup" : [ { "@value" : "HYPOTENSIVA" , "@language" : "cs" } ] ,      "http://linked.opendata.cz/ontology/drug-encyclopedia/hasSPCDocument" : [ "http://linked.opendata.cz/resource/sukl/spc/document/SPC156709_doc" ] ,      "http://linked.opendata.cz/ontology/drug-encyclopedia/hasPackagingSize" : [ { "@value" : "3X10" , "@type" : "http://www.w3.org/2001/XMLSchema#string" } ] ,      "http://linked.opendata.cz/ontology/drug-encyclopedia/hasRouteOfAdministration" : [ { "@value" : "Peror\u00E1ln\u00ED pod\u00E1n\u00ED" , "@language" : "cs" } ] ,      "http://linked.opendata.cz/ontology/drug-encyclopedia/hasIndication" : [ { "@value" : "Egiramlon\u00A0je indikov\u00E1n k\u00A0l\u00E9\u010Db\u011B hypertenze jako substitu\u010Dn\u00ED l\u00E9\u010Dba u dosp\u011Bl\u00FDch pacient\u016F dostate\u010Dn\u011B l\u00E9\u010Den\u00FDch jednotliv\u00FDmi p\u0159\u00EDpravky pod\u00E1van\u00FDmi soub\u011B\u017En\u011B ve stejn\u00FDch d\u00E1vk\u00E1ch jako v\u00A0kombinovan\u00E9m p\u0159\u00EDpravku, ale ve form\u011B samostatn\u00FDch tablet.\n" , "@language" : "cs" } ] ,      "http://linked.opendata.cz/ontology/drug-encyclopedia/hasRegistrationState" : [ "http://linked.opendata.cz/resource/sukl/registration-state/R" ] ,      "http://linked.opendata.cz/ontology/drug-encyclopedia/hasTitleSupplement" : [ { "@value" : "POR CPS DUR 30" , "@language" : "cs" } ] } ,    { "@id": "http://linked.opendata.cz/resource/sukl/medicinal-product-packaging/0177276",      "@type" : [ "http://linked.opendata.cz/ontology/drug-encyclopedia/MedicinalProductPackaging" ] ,      "http://linked.opendata.cz/ontology/drug-encyclopedia/title" : [ { "@value" : "EGIRAMLON 2,5 MG/2,5 MG" , "@language" : "cs" } ] ,      "http://linked.opendata.cz/ontology/drug-encyclopedia/hasATCConcept" : [ "http://linked.opendata.cz/resource/ATC/C09BB07" ] ,      "http://linked.opendata.cz/ontology/drug-encyclopedia/hasIndicationGroup" : [ { "@value" : "HYPOTENSIVA" , "@language" : "cs" } ] ,      "http://linked.opendata.cz/ontology/drug-encyclopedia/hasSPCDocument" : [ "http://linked.opendata.cz/resource/sukl/spc/document/SPC156709_doc" ] ,      "http://linked.opendata.cz/ontology/drug-encyclopedia/hasPackagingSize" : [ { "@value" : "9X10" , "@type" : "http://www.w3.org/2001/XMLSchema#string" } ] ,      "http://linked.opendata.cz/ontology/drug-encyclopedia/hasRouteOfAdministration" : [ { "@value" : "Peror\u00E1ln\u00ED pod\u00E1n\u00ED" , "@language" : "cs" } ] ,      "http://linked.opendata.cz/ontology/drug-encyclopedia/hasIndication" : [ { "@value" : "Egiramlon\u00A0je indikov\u00E1n k\u00A0l\u00E9\u010Db\u011B hypertenze jako substitu\u010Dn\u00ED l\u00E9\u010Dba u dosp\u011Bl\u00FDch pacient\u016F dostate\u010Dn\u011B l\u00E9\u010Den\u00FDch jednotliv\u00FDmi p\u0159\u00EDpravky pod\u00E1van\u00FDmi soub\u011B\u017En\u011B ve stejn\u00FDch d\u00E1vk\u00E1ch jako v\u00A0kombinovan\u00E9m p\u0159\u00EDpravku, ale ve form\u011B samostatn\u00FDch tablet.\n" , "@language" : "cs" } ] ,      "http://linked.opendata.cz/ontology/drug-encyclopedia/hasRegistrationState" : [ "http://linked.opendata.cz/resource/sukl/registration-state/R" ] ,      "http://linked.opendata.cz/ontology/drug-encyclopedia/hasTitleSupplement" : [ { "@value" : "POR CPS DUR 90" , "@language" : "cs" } ] } ,    { "@id": "http://linked.opendata.cz/resource/sukl/medicinal-product-packaging/0177272",      "@type" : [ "http://linked.opendata.cz/ontology/drug-encyclopedia/MedicinalProductPackaging" ] ,      "http://linked.opendata.cz/ontology/drug-encyclopedia/title" : [ { "@value" : "EGIRAMLON 2,5 MG/2,5 MG" , "@language" : "cs" } ] ,      "http://linked.opendata.cz/ontology/drug-encyclopedia/hasATCConcept" : [ "http://linked.opendata.cz/resource/ATC/C09BB07" ] ,      "http://linked.opendata.cz/ontology/drug-encyclopedia/hasIndicationGroup" : [ { "@value" : "HYPOTENSIVA" , "@language" : "cs" } ] ,      "http://linked.opendata.cz/ontology/drug-encyclopedia/hasSPCDocument" : [ "http://linked.opendata.cz/resource/sukl/spc/document/SPC156709_doc" ] ,      "http://linked.opendata.cz/ontology/drug-encyclopedia/hasPackagingSize" : [ { "@value" : "4X7" , "@type" : "http://www.w3.org/2001/XMLSchema#string" } ] ,      "http://linked.opendata.cz/ontology/drug-encyclopedia/hasRouteOfAdministration" : [ { "@value" : "Peror\u00E1ln\u00ED pod\u00E1n\u00ED" , "@language" : "cs" } ] ,      "http://linked.opendata.cz/ontology/drug-encyclopedia/hasIndication" : [ { "@value" : "Egiramlon\u00A0je indikov\u00E1n k\u00A0l\u00E9\u010Db\u011B hypertenze jako substitu\u010Dn\u00ED l\u00E9\u010Dba u dosp\u011Bl\u00FDch pacient\u016F dostate\u010Dn\u011B l\u00E9\u010Den\u00FDch jednotliv\u00FDmi p\u0159\u00EDpravky pod\u00E1van\u00FDmi soub\u011B\u017En\u011B ve stejn\u00FDch d\u00E1vk\u00E1ch jako v\u00A0kombinovan\u00E9m p\u0159\u00EDpravku, ale ve form\u011B samostatn\u00FDch tablet.\n" , "@language" : "cs" } ] ,      "http://linked.opendata.cz/ontology/drug-encyclopedia/hasRegistrationState" : [ "http://linked.opendata.cz/resource/sukl/registration-state/R" ] ,      "http://linked.opendata.cz/ontology/drug-encyclopedia/hasTitleSupplement" : [ { "@value" : "POR CPS DUR 28" , "@language" : "cs" } ] } ,    { "@id": "http://linked.opendata.cz/resource/sukl/medicinal-product-packaging/0177273",      "@type" : [ "http://linked.opendata.cz/ontology/drug-encyclopedia/MedicinalProductPackaging" ] ,      "http://linked.opendata.cz/ontology/drug-encyclopedia/title" : [ { "@value" : "EGIRAMLON 2,5 MG/2,5 MG" , "@language" : "cs" } ] ,      "http://linked.opendata.cz/ontology/drug-encyclopedia/hasATCConcept" : [ "http://linked.opendata.cz/resource/ATC/C09BB07" ] ,      "http://linked.opendata.cz/ontology/drug-encyclopedia/hasIndicationGroup" : [ { "@value" : "HYPOTENSIVA" , "@language" : "cs" } ] ,      "http://linked.opendata.cz/ontology/drug-encyclopedia/hasSPCDocument" : [ "http://linked.opendata.cz/resource/sukl/spc/document/SPC156709_doc" ] ,      "http://linked.opendata.cz/ontology/drug-encyclopedia/hasPackagingSize" : [ { "@value" : "8X7" , "@type" : "http://www.w3.org/2001/XMLSchema#string" } ] ,      "http://linked.opendata.cz/ontology/drug-encyclopedia/hasRouteOfAdministration" : [ { "@value" : "Peror\u00E1ln\u00ED pod\u00E1n\u00ED" , "@language" : "cs" } ] ,      "http://linked.opendata.cz/ontology/drug-encyclopedia/hasIndication" : [ { "@value" : "Egiramlon\u00A0je indikov\u00E1n k\u00A0l\u00E9\u010Db\u011B hypertenze jako substitu\u010Dn\u00ED l\u00E9\u010Dba u dosp\u011Bl\u00FDch pacient\u016F dostate\u010Dn\u011B l\u00E9\u010Den\u00FDch jednotliv\u00FDmi p\u0159\u00EDpravky pod\u00E1van\u00FDmi soub\u011B\u017En\u011B ve stejn\u00FDch d\u00E1vk\u00E1ch jako v\u00A0kombinovan\u00E9m p\u0159\u00EDpravku, ale ve form\u011B samostatn\u00FDch tablet.\n" , "@language" : "cs" } ] ,      "http://linked.opendata.cz/ontology/drug-encyclopedia/hasRegistrationState" : [ "http://linked.opendata.cz/resource/sukl/registration-state/R" ] ,      "http://linked.opendata.cz/ontology/drug-encyclopedia/hasTitleSupplement" : [ { "@value" : "POR CPS DUR 56" , "@language" : "cs" } ] } ,    { "@id": "http://linked.opendata.cz/resource/sukl/medicinal-product-packaging/0177275",      "@type" : [ "http://linked.opendata.cz/ontology/drug-encyclopedia/MedicinalProductPackaging" ] ,      "http://linked.opendata.cz/ontology/drug-encyclopedia/title" : [ { "@value" : "EGIRAMLON 2,5 MG/2,5 MG" , "@language" : "cs" } ] ,      "http://linked.opendata.cz/ontology/drug-encyclopedia/hasATCConcept" : [ "http://linked.opendata.cz/resource/ATC/C09BB07" ] ,      "http://linked.opendata.cz/ontology/drug-encyclopedia/hasIndicationGroup" : [ { "@value" : "HYPOTENSIVA" , "@language" : "cs" } ] ,      "http://linked.opendata.cz/ontology/drug-encyclopedia/hasSPCDocument" : [ "http://linked.opendata.cz/resource/sukl/spc/document/SPC156709_doc" ] ,      "http://linked.opendata.cz/ontology/drug-encyclopedia/hasPackagingSize" : [ { "@value" : "6X10" , "@type" : "http://www.w3.org/2001/XMLSchema#string" } ] ,      "http://linked.opendata.cz/ontology/drug-encyclopedia/hasRouteOfAdministration" : [ { "@value" : "Peror\u00E1ln\u00ED pod\u00E1n\u00ED" , "@language" : "cs" } ] ,      "http://linked.opendata.cz/ontology/drug-encyclopedia/hasIndication" : [ { "@value" : "Egiramlon\u00A0je indikov\u00E1n k\u00A0l\u00E9\u010Db\u011B hypertenze jako substitu\u010Dn\u00ED l\u00E9\u010Dba u dosp\u011Bl\u00FDch pacient\u016F dostate\u010Dn\u011B l\u00E9\u010Den\u00FDch jednotliv\u00FDmi p\u0159\u00EDpravky pod\u00E1van\u00FDmi soub\u011B\u017En\u011B ve stejn\u00FDch d\u00E1vk\u00E1ch jako v\u00A0kombinovan\u00E9m p\u0159\u00EDpravku, ale ve form\u011B samostatn\u00FDch tablet.\n" , "@language" : "cs" } ] ,      "http://linked.opendata.cz/ontology/drug-encyclopedia/hasRegistrationState" : [ "http://linked.opendata.cz/resource/sukl/registration-state/R" ] ,      "http://linked.opendata.cz/ontology/drug-encyclopedia/hasTitleSupplement" : [ { "@value" : "POR CPS DUR 60" , "@language" : "cs" } ] }] }